Terns Pharmaceuticals (TERN) had the highest return between August 1, 2022 and September 30, 2022 by a small-cap US stock, returning 168.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Terns Pharmaceuticals (TERN) | 8/1/2022 - 9/30/2022 | 168.95% |
Astria Therapeutics (ATXS) | 8/1/2022 - 9/30/2022 | 121.57% |
EVI Industries (EVI) | 8/1/2022 - 9/30/2022 | 119.88% |
Prothena (PRTA) | 8/1/2022 - 9/30/2022 | 98.66% |
Enliven Therapeutics (ELVN) | 8/1/2022 - 9/30/2022 | 98.26% |
Harrow Health (HROW) | 8/1/2022 - 9/30/2022 | 80.96% |
Ardelyx (ARDX) | 8/1/2022 - 9/30/2022 | 72.46% |
Larimar Therapeutics (LRMR) | 8/1/2022 - 9/30/2022 | 71.12% |
89bio (ETNB) | 8/1/2022 - 9/30/2022 | 63.56% |
Applied Opt (AAOI) | 8/1/2022 - 9/30/2022 | 60% |
Viridian Therapeutics (VRDN) | 8/1/2022 - 9/30/2022 | 57.04% |
Sigma Lithium Resources (SGML) | 8/1/2022 - 9/30/2022 | 54.14% |
Pulse Biosciences (PLSE) | 8/1/2022 - 9/30/2022 | 44.65% |
Wave Life Sciences (WVE) | 8/1/2022 - 9/30/2022 | 43.25% |
NioCorp Developments Ltd Common Stock (NB) | 8/1/2022 - 9/30/2022 | 42.86% |
Fubotv (FUBO) | 8/1/2022 - 9/30/2022 | 42.57% |
Limbach (LMB) | 8/1/2022 - 9/30/2022 | 42.06% |
SS Innovations International Inc Common Stock (SSII) | 8/1/2022 - 9/30/2022 | 41.94% |
Verve Therapeutics (VERV) | 8/1/2022 - 9/30/2022 | 40.26% |
Precigen (PGEN) | 8/1/2022 - 9/30/2022 | 39.47% |
Aquestive Therapeutics (AQST) | 8/1/2022 - 9/30/2022 | 39.29% |
Cricut (CRCT) | 8/1/2022 - 9/30/2022 | 37.59% |
Fulcrum Therapeutics (FULC) | 8/1/2022 - 9/30/2022 | 37.59% |
Cogent Biosciences (COGT) | 8/1/2022 - 9/30/2022 | 34.41% |
Cooper Stnd (CPS) | 8/1/2022 - 9/30/2022 | 34.25% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
